Fhit modulates the DNA damage checkpoint response. Ishii H, Mimori K, Inoue H, Inageta T, Ishikawa K, Semba S, Druck T, Trapasso F, Tani K, Vecchione A, Croce CM, Mori M, Huebner K. Cancer Res. 2006 Dec 1;66(23):11287-92. Gene expression profiling of lymph node metastasis by oligomicroarray analysis […]

Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Nagahara H, Mimori K, Utsunomiya T, Barnard GF, Ohira M, Hirakawa K, Mori M. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6800-6. Epidermal growth factor receptor gene is highly conserved in pancreatic c […]

Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells. Mimori K, Yamashita K, Ohta M, Yoshinaga K, Ishikawa K, Ishii H, Utsunomiya T, Barnard GF, […]

A tumor-suppressive role for trypsin in human cancer progression. Yamashita K, Mimori K, Inoue H, Mori M, Sidransky D. Cancer Res. 2003 Oct 15;63(20):6575-8. Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil domain kinase messenger RNA expression and promotes cell m […]

Prognostic score of gastric cancer determined by cDNA microarray. Inoue H, Matsuyama A, Mimori K, Ueo H, Mori M. Clin Cancer Res. 2002 Nov;8(11):3475-9. A single-nucleotide polymorphism of SMARCB1 in human breast cancers. Mimori K, Inoue H, Shiraishi T, Ueo H, Mafune K, Tanaka Y, Mori M. Genomics. 2 […]

Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma. Mori M, Mimori K, Masuda T, Yoshinaga K, Yamashita K, Matsuyama A, Inoue H. Cancer Res. 2001 Oct 15;61(20):7379-82. Cancer-specific chromosome alterations in the co […]